AI-generated summary
The authors evaluated photobiomodulation therapy, alone or combined with photodynamic therapy using curcumin, in 31 cancer patients with oral mucositis from chemotherapy or radiotherapy. Both approaches reduced mucositis grade, and the combined treatment was associated with a shorter healing time. The study was conducted with patients divided by convenience into two groups, so the authors note results apply within the parameters of this study.
- Participants
- 31
- Who or what was studied
- Cancer patients receiving chemotherapy and/or radiotherapy who had oral mucositis
- Wavelengths
- 660, 468 nm
- Limits stated in the abstract
- Patients were divided by convenience rather than randomized, and the authors state conclusions apply only within the parameters of this study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 468 nm
- Energy density (fluence)
- 142 J/cm2
- Total energy
- 4 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photodynamic therapy, Photobiomodulation therapy, Wavelength, Light-emitting diode, Oral mucositis, GRADE, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.